EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Flux Sampling Suggests Metabolic Signatures of High Antibody‐Producing CHO Cells

Kate E Meeson iD, Joanne Watson iD, Susan Rosser iD, Ellie Hawke, Andrew Pitt iD, Tessa Moses iD, Leon Pybus iD, Magnus Rattray iD, Alan J Dickson iD, Jean-Marc Schwartz

Biotechnology and Bioengineering · 2025-07 · 122 (7) · 1898-1913

DOI: 10.1002/bit.28982 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2025-04-11. Written by Kate E Meeson and 9 co-authors. Institution: Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Major MEDLINE topics: Antibodies, Monoclonal, Recombinant Proteins, Models, Biological, Metabolic Flux Analysis. Cited 8 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY 4.0). Funded by: The authors acknowledge financial support from a Prosperity Partnership grant (EP/V038095/1) funded by EPSRC, BBSRC, and FUJIFILM Diosynth Biotechnologies. Thi…, Engineering and Physical Sciences Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chinese hamster ovary (CHO) cells remain the industry standard for producing numerous therapeutic proteins, particularly monoclonal antibodies (mAbs). However, achieving higher recombinant protein titers remains an ongoing challenge and a fundamental understanding of the cellular mechanism driving improved bioprocess performance remains elusive. To directly address these challenges and achieve substantial improvements, a more in‐depth understanding of cellular function within a bioprocess environment may be required. Over the past decade, significant advancements have been made in the building of genome‐scale metabolic models (GEMs) for CHO cells, bridging the gap between high information content 'omics data and the ability to perform in silico phenotypic predictions. Here, time‐course transcriptomics has been employed to constrain culture phase‐specific GEMs, representing the early exponential, late exponential, and stationary/death phases of CHO cell fed‐batch bioreactor culture. Temporal bioprocess data, including metabolite uptake and secretion rates, as well as growth and productivity, has been used to validate flux sampling results. Additionally, high mAb‐producing solutions have been identified and the metabolic signatures associated with improved mAb production have been hypothesized. Finally, constraint‐based modeling has been utilized to infer specific amino acids, cysteine, histidine, leucine, isoleucine, asparagine, and serine, which could drive increased mAb production and guide optimal media and feed formulations.

Subjects

MeSH terms (MEDLINE)

Antibodies, MonoclonalRecombinant ProteinsModels, BiologicalMetabolic Flux AnalysisMetabolomeCHO CellsAnimalsCricetulusCricetinaeBioreactors

Substances

Antibodies, MonoclonalRecombinant Proteins

Authors and institutions

  • Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.
  • EdinOmics, RRID:SCR_021838, Centre for Engineering Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, UK.
  • FUJIFILM Diosynth Biotechnologies, Billingham, UK.

ORCID profiles: Kate E Meeson, Joanne Watson, Susan Rosser, Andrew Pitt, Tessa Moses, Leon Pybus, Magnus Rattray, Alan J Dickson

Funding

  • The authors acknowledge financial support from a Prosperity Partnership grant (EP/V038095/1) funded by EPSRC, BBSRC, and FUJIFILM Diosynth Biotechnologies. Thi…
  • Engineering and Physical Sciences Research Council

Cite

APA

Meeson, K. E., Watson, J., Rosser, S., Hawke, E., Pitt, A., Moses, T., Pybus, L., Rattray, M., Dickson, A. J., & Schwartz, J. M. (2025). Flux Sampling Suggests Metabolic Signatures of High Antibody‐Producing CHO Cells. Biotechnology and Bioengineering, 122(7), 1898-1913. https://doi.org/10.1002/bit.28982

Vancouver

Meeson KE, Watson J, Rosser S, Hawke E, Pitt A, Moses T, et al. Flux Sampling Suggests Metabolic Signatures of High Antibody‐Producing CHO Cells. Biotechnology and Bioengineering. 2025;122(7):1898-1913. doi:10.1002/bit.28982

BibTeX
@article{Meeson2025,
  author = {Meeson, Kate E and Watson, Joanne and Rosser, Susan and Hawke, Ellie and Pitt, Andrew and Moses, Tessa and Pybus, Leon and Rattray, Magnus and Dickson, Alan J and Schwartz, Jean-Marc},
  title = {Flux Sampling Suggests Metabolic Signatures of High Antibody‐Producing CHO Cells},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  volume = {122},
  number = {7},
  pages = {1898--1913},
  doi = {10.1002/bit.28982}
}
Start for free →